Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

GenVec GNVC

"Genvec Inc is a biopharmaceutical company. The Company is engaged in leveraging its proprietary AdenoVerse gene delivery platform to develop a pipeline of cutting-edge therapeutics and vaccines."


NDAQ:GNVC - Post by User

Comment by SurajKGuptaon May 27, 2008 10:14pm
457 Views
Post# 15116715

RE: Fundamental analysis difficulties

RE: Fundamental analysis difficultiesI think they have some good potential for innovation, hence the grant received, however I think that there is no question they should attempt to create more long-term liabilities for themselves instead of attempting to finance their transactions through equity.  They only have $1.2 million in long-term liabilities, and they have$12.3 million in current liabilities that will be paid off within 12 months, meaning their cash will be depleted but they won't have any severe interest payments.  They have room to take out some debt and finance some new innovations in order to raise their share price and spark a better company future.
<< Previous
Bullboard Posts
Next >>